Advanced search
Publication Cover
International Journal of General Medicine Volume 13, 2020 - Issue
Submit an article Journal homepage
122
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review

Huijie Dong1 First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310053, People’s Republic of ChinaView further author information
,
Yingying Shen1 First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310053, People’s Republic of China;2 Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310006, People’s Republic of ChinaView further author information
,
Yiping Shen1 First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310053, People’s Republic of China;2 Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310006, People’s Republic of ChinaView further author information
&
Dijiong Wu1 First Clinical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310053, People’s Republic of China;2 Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang310006, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2338-9365View further author information
ORCID Icon
Pages 1187-1192 | Published online: 19 Nov 2020

References

  • Robak T. Management of hairy cell leukemia variant. Leuk Lymphoma. 2011;52(Suppl 2):53–56. doi:10.3109/10428194.2011.566392
  • Tiacci E, Pettirossi V, Schiavoni G, Falini B. Genomics of hairy cell leukemia. J Clin Oncol. 2017;35(9):1002–1010. doi:10.1200/JCO.2016.71.155628297625
  • Wang HY, Zu Y. Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry. Arch Pathol Lab Med. 2017;141(9):1236–1246. doi:10.5858/arpa.2016-0521-RA28608720
  • Dong HY, Weisberger J, Liu Z, Tugulea S. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am J Clin Pathol. 2009;131(4):586–595. doi:10.1309/AJCPL13YDUHFKPJU19289595
  • Benz R, Arn K, Andres M, et al. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Adv. 2020;4(15):3699–3707. doi:10.1182/bloodadvances.202000216032777066
  • Grever MR, Abdel-Wahab O, Andritsos LA, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017;129(5):553–560. doi:10.1182/blood-2016-01-68942227903528
  • Bibi A, Java S, Chaudhary S, et al. BRAFV600E mutation in hairy cell leukemia: a single-center experience. Indian J Pathol Microbiol. 2018;61(4):532–536.30303143
  • Rosenberg JD, Burian C, Waalen J, Saven A. Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series. Blood. 2014;123(2):177–183. doi:10.1182/blood-2013-06-50875424192579
  • Ganzel C, Gatt ME, Maly A, Ben-Yehuda D, Goldschmidt N. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine. Leuk Lymphoma. 2012;53(6):1169–1173. doi:10.3109/10428194.2011.63586422035415
  • Sigal DS, Miller HJ, Schram ED, Saven A. Beyond hairy cell: the activity of cladribine in other hematologic malignancies. Blood. 2010;116(16):2884–2896. doi:10.1182/blood-2010-02-24614020634380
  • Wang TY, Li ZJ, Lyu R, et al. [Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine]. Zhonghua Xue Ye Xue Za Zhi. 2018;39(6):491–495.30032567
  • Chubar Y, Bennett M. Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. Br J Haematol. 2003;122(5):768–770. doi:10.1046/j.1365-2141.2003.04506.x12930387
  • Espinosa Lara P, Quiros Redondo V, Aguado Lobo M, Jimenez-Reyes J. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol. Ann Hematol. 2017;96(7):1209–1210. doi:10.1007/s00277-017-2992-z28391438
  • Grey MR, Flanagan NG, Kelsey PR. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Clin Lab Haematol. 2000;22(2):111–113. doi:10.1046/j.1365-2257.2000.00283.x10792402
  • Kreitman RJ. Hairy cell leukemia: present and future directions. Leuk Lymphoma. 2019;60(12):2869–2879. doi:10.1080/10428194.2019.160853631068044
  • Johnston JB, Glazer RI, Pugh L, Israels LG. The treatment of hairy-cell leukaemia with 2ʹ-deoxycoformycin. Br J Haematol. 1986;63(3):525–534. doi:10.1111/j.1365-2141.1986.tb07530.x3488071
  • Meunier P, Castaigne S, Bastie JN, Chosidow O, Aractingi S. Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol. 1996;76(5):385–386.8891014
  • Robak T, Sysa-Jedrzejowska A, Robak E, Dabkowski J, Blasinska-Morawiec M. 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia. J Med. 1997;28(3–4):199–209.9355024
  • Rossini MS, de Souza EM, Cintra ML, Pagnano KB, Chiari AC, Lorand-Metze I. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol. 2004;18(5):538–542. doi:10.1111/j.1468-3083.2004.00969.x15324388
  • Cook S, Vermersch P, Comi G, et al. Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Mult Scler. 2011;17(5):578–593. doi:10.1177/135245851039134421228029

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.